Periodic Reporting for period 3 - VERDAD (A blood based biomarker identifying early Alzheimer Disease's pathology)

Alzheimer’s Disease (AD) is a global pandemic, representing a €300 bn yearly expenditure in EU and affecting ~10% of its population above 65 years old. However, it has been estimated that a five-year delay in the disease onset could reduce the disease prevalence – and...